Market LIVE
Published markets; coverage varies by country
Product profile · United States

Xgeva

 ·  Patent Litigation & Settlement History ↓

Ingredientdenosumab
Application typeBLA
Application125320
Product003
Dosage formInjection
RouteSubcutaneous
Strength120MG/1.7ML (70MG/ML)
Approval date2010-11-18
Marketing statusPrescription
Status event—
ApplicantAMGEN
Product source

Current GenericRadar decision

Year2025
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2025-02-19
Patent anchor2025-02-19
Exclusivity anchor2022-06-01
Protection date—
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2025. Anchor type: PATENT. Patent anchor: 2025-02-19. Exclusivity anchor: 2022-06-01. Anchor date: 2025-02-19. Patent tail: not established. Exclusivity tail: not established. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
80584182023-11-30PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
73647362025-02-19PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
74276592025-03-15PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
82472102026-12-06PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
84608962026-12-06PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
86802482026-12-06PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
82171532027-01-05PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
79282052027-02-12PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
78881012027-04-06PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
76629302027-04-24PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
93594352027-05-22PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
80532362030-01-19PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
92281682030-01-19PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
93208162030-11-14PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
90121782031-08-05PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
91334932032-04-20PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
93884472032-04-20PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
112928292032-06-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
116344762032-06-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
116857722032-06-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
93715542032-12-14PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
112939302033-03-26PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
114868832033-03-26PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
93281342034-02-20PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
113195682034-03-10PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
114595952034-03-10PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
119526052034-03-10PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
120846862034-03-10PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
114923722034-03-11PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
104219872034-05-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
108949722034-05-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
114345142034-05-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
119460852034-05-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
94819012034-05-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
98031662034-09-29PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
112997602034-10-30PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
105137232034-12-09PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
112549632034-12-09PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
101068292034-12-11PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
102276272034-12-11PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
106551562034-12-11PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
109071862034-12-11PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
111309802035-04-05PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
110774042035-05-13PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
113843782035-06-04PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
114278482035-06-04PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
105833972035-07-28PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
117868662035-10-21PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
111929192035-11-13PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
101674922035-12-01PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
108226302035-12-01PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
112750902037-07-02PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
110980792037-07-21PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
98813672037-08-09PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
120256182039-08-26PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
117449502039-11-21PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———
120595552040-09-02PURPLE_BOOK ————
Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
Orphan Exclusivity Exp. Date—2021-12-05————Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
761362 / 002BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2024-03-05—Sandoz Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761362 / 002INTERCHANGEABILITY · INTERCHANGEABLE——Sandoz Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761392 / 002BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-02-13—Samsung Bioepis Co., Ltd.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761404 / 002BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-02-28—CELLTRION, Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761398 / 002BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-03-25—Fresenius Kabi USA, LLCNREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761398 / 003BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-03-25—Fresenius Kabi USA, LLCNREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761444 / 003BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-08-29—Shanghai Henlius Biotech, Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761436 / 002BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-09-16—Biocon Biologics Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761439 / 002BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-09-26—Hikma Pharmaceuticals USA Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761392 / 002INTERCHANGEABILITY · INTERCHANGEABLE——Samsung Bioepis Co., Ltd.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761398 / 002INTERCHANGEABILITY · INTERCHANGEABLE——Fresenius Kabi USA, LLCNREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761398 / 003INTERCHANGEABILITY · INTERCHANGEABLE——Fresenius Kabi USA, LLCNREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761404 / 002INTERCHANGEABILITY · INTERCHANGEABLE——CELLTRION, Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761424 / 002INTERCHANGEABILITY · INTERCHANGEABLE——Accord BioPharma Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761424 / 002BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-10-29—Accord BioPharma Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761436 / 002INTERCHANGEABILITY · INTERCHANGEABLE——Biocon Biologics Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761439 / 002INTERCHANGEABILITY · INTERCHANGEABLE——Hikma Pharmaceuticals USA Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761444 / 003INTERCHANGEABILITY · INTERCHANGEABLE——Shanghai Henlius Biotech, Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761457 / 001BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-12-19—Amneal Pharmaceuticals LLCNREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761457 / 001INTERCHANGEABILITY · INTERCHANGEABLE——Amneal Pharmaceuticals LLCNREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761481 / 001INTERCHANGEABILITY · INTERCHANGEABLE——Teva Pharmaceuticals, Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource
761481 / 001BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2026-09-25—Teva Pharmaceuticals, Inc.NREFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 11 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
761362 / 002Sandoz Inc.BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2024-03-05 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761392 / 002Samsung Bioepis Co., Ltd.BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-02-13 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761404 / 002CELLTRION, Inc.BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-02-28 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761398 / 002Fresenius Kabi USA, LLCBIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-03-25 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761398 / 003Fresenius Kabi USA, LLCBIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-03-25 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761444 / 003Shanghai Henlius Biotech, Inc.BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-08-29 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761436 / 002Biocon Biologics Inc.BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-09-16 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761439 / 002Hikma Pharmaceuticals USA Inc.BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-09-26 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761424 / 002Accord BioPharma Inc.BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-10-29 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761457 / 001Amneal Pharmaceuticals LLCBIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2025-12-19 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
761481 / 001Teva Pharmaceuticals, Inc.BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED2026-09-25 REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Decision evidence (1)
TypeDateRoleBasisSource
BLA_PATENT_EXCLUSIVITY_REVIEW—BUSINESS_CLASSIFICATION_WITH_CONDITIONSEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.